z-logo
open-access-imgOpen Access
Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability
Author(s) -
Cynthia L. Gay,
Sarah J. Willis,
Anna B. Cope,
Jo Ann D. Kuruc,
Kara McGee,
J. S. Sebastian,
Amanda M. Crooks,
Mehri McKellar,
David M. Margolis,
Susan A. Fiscus,
Charles B. Hicks,
Guido Ferrari,
Joseph J. Eron
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/2zer-k998
Subject(s) - efavirenz , emtricitabine , tenofovir , human immunodeficiency virus (hiv) , medicine , virology , pharmacology , antiretroviral therapy , viral load

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here